Gerriets T, Stolz E, Walberer M, Kaps M, Bachmann G, Fisher M
Department of Radiology, Experimental Neurology Research Group, Kerckhoff Klinik Bad, Nauheim, Germany.
Stroke. 2003 Sep;34(9):2234-9. doi: 10.1161/01.STR.0000087171.34637.A9. Epub 2003 Aug 14.
Permanent middle cerebral artery occlusion (MCAO) with the use of the suture technique causes hypothalamic damage with subsequent hyperthermia, which can confound neuroprotective drug studies. In the present study the neuroprotective effects of dizocilpine (MK-801) were compared in different permanent MCAO models with and without hypothalamic damage and hyperthermia.
Sixty Sprague-Dawley rats were treated with MK-801 or placebo, beginning 15 minutes before MCAO, and assigned to the following groups: suture MCAO (group I), macrosphere MCAO without hypothalamic damage (group II), or macrosphere MCAO with intentionally induced hypothalamic infarction (group III). Body temperature was measured at 3, 6, and 24 hours. Lesion size was determined after 24 hours (2,3,5-triphenyltetrazolium chloride staining).
Hypothalamic damage was present in animals in group I and was intentionally induced in group III with the use of a modified macrosphere MCAO technique. Body temperature was significantly increased 3, 6, and 24 hours after MCAO in these 2 groups of animals. Hypothalamic damage and subsequent hyperthermia could be avoided effectively by limiting the number of macrospheres (group II). MK-801 provided a highly significant neuroprotective effect in group II but not in groups I and III.
Hypothalamic damage with subsequent hyperthermia masked the neuroprotective effect of MK-801. This side effect can be avoided by using the macrosphere MCAO technique with a limited number of spheres. This model therefore may be more appropriate to study the effects of neuroprotective drugs in permanent focal cerebral ischemia than the suture method.
采用缝合技术进行永久性大脑中动脉闭塞(MCAO)会导致下丘脑损伤及随后的体温过高,这可能会干扰神经保护药物的研究。在本研究中,比较了在有或无下丘脑损伤及体温过高的不同永久性MCAO模型中,地佐环平(MK-801)的神经保护作用。
60只Sprague-Dawley大鼠在MCAO前15分钟接受MK-801或安慰剂治疗,并分为以下几组:缝合MCAO组(I组)、无下丘脑损伤的微球MCAO组(II组)或有意诱导下丘脑梗死的微球MCAO组(III组)。在3、6和24小时测量体温。24小时后(采用2,3,5-三苯基氯化四氮唑染色)确定损伤大小。
I组动物存在下丘脑损伤,III组采用改良的微球MCAO技术有意诱导下丘脑损伤。这两组动物在MCAO后3、6和24小时体温显著升高。通过限制微球数量(II组)可有效避免下丘脑损伤及随后的体温过高。MK-801在II组具有高度显著的神经保护作用,但在I组和III组中则不然。
下丘脑损伤及随后的体温过高掩盖了MK-801的神经保护作用。采用微球数量有限的微球MCAO技术可避免这种副作用。因此,该模型可能比缝合方法更适合研究神经保护药物在永久性局灶性脑缺血中的作用。